ThermaCare HeatWraps Recall Is Second In Seven Months By Pfizer
Executive Summary
Pfizer Consumer Healthcare division recalls one lot of ThermaCare Back Pain Therapy HeatWraps, up to 16HR pain relief, because the products could include cells that have a higher cell temperature than specified. Firm in late 2018 recalled six lots of ThermaCare HeatWraps Muscle Joint Therapy 8-hour strength due to reports of leaking heat cells.
You may also be interested in...
GSK And Pfizer Agree To Divest ThermaCare To Win EU Approval For JV
GSK and Pfizer must find a buyer for the global rights to the ThermaCare pain relief brand to receive European Commission approval for their proposed joint venture.
Leaking Heat Cells In Pfizer's ThermaCare HeatWraps Prompt Recall
Firm's consumer health division extends to consumer level a recall it advised retailers and distributors about on Oct. 2 because products from the six lots have a potential to leak ingredients contained in heat cell wraps. A leaking heat cell in a HeatWrap could cause skin injuries such as burns, blisters or skin irritation on the applied areas.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”